U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862102) titled 'MULTIPLE HUMAN PAPILLOMAVIRUS INFECTIONS in CIN DEVELOPMENT' on March 01.
Brief Summary: Multiple infections of high-risk genotypes of Human Papillomavirus (HR-HPV) in patients with abnormal cervical cytological or histological findings are detectable in a percentage ranging from 20% to 50% of cases.
Some studies have detected a certain tendency to specific clustering in multiple infections, both inter-species and inter-genotypic, such as HPV 31-35-56, HPV 16-51-52, HPV 16-18, HPV 51-52. Furthermore, a greater tendency of the HPV16 genotype to cluster with genotypes of different species is reported in the literature. However, other...